Impaired Pulmonary V˙O2 Kinetics in Cystic Fibrosis Depend on Exercise Intensity

Zoe Louise Saynor1, Alan Robert Barker, Patrick John Oades

  • 11Children's Health and Exercise Research Centre, Sport and Health Sciences, University of Exeter, Exeter, Devon, UNITED KINGDOM; and 2Paediatric Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UNITED KINGDOM.

Insights

Children with cystic fibrosis (CF) show slower pulmonary oxygen uptake (V˙O2) kinetics during very heavy exercise, indicating intensity-dependent impairments in muscle oxygen use. This impacts their ability to utilize oxygen efficiently during strenuous physical activity.

Area of Science:

  • Exercise Physiology
  • Pediatric Pulmonology
  • Cardiorespiratory Fitness

Background:

  • Cystic Fibrosis (CF) affects multiple organs, including the lungs, potentially impacting exercise capacity.
  • Understanding the kinetics of pulmonary oxygen uptake (V˙O2) is crucial for assessing cardiorespiratory function during exercise.
  • Pediatric patients with mild-to-moderate CF may exhibit subtle impairments in oxygen utilization during physical exertion.

Purpose of the Study:

  • To investigate the effects of mild-to-moderate cystic fibrosis (CF) on pulmonary oxygen uptake (V˙O2) kinetics in pediatric patients.
  • To compare V˙O2 kinetics during moderate (MOD) and very heavy (VH) intensity cycling exercise between CF patients and healthy controls.
  • To determine if CF-related impairments in V˙O2 kinetics are intensity-dependent and linked to central or peripheral factors.

Main Methods:

  • Seven pediatric patients with mild-to-moderate CF and seven healthy matched controls performed repeat transitions to MOD and VH intensity cycling.
  • Breath-by-breath V˙O2, vastus lateralis muscle deoxygenation ([HHb]) via near-infrared spectroscopy, and cardiac function (HR, SV index, CI) were measured.
  • Phase II V˙O2 time constant (τ) and mean response time (MRT) were calculated to assess V˙O2 kinetics.

Main Results:

  • During MOD exercise, V˙O2 kinetics (phase II τ and MRT) were not significantly different between CF patients and controls.
  • During VH exercise, V˙O2 kinetics (phase II τ and MRT) were significantly slower in CF patients compared to controls.
  • Reduced arteriovenous O2 content difference was observed in CF patients during VH exercise, correlating with slower V˙O2 kinetics.

Conclusions:

  • Impaired muscle oxidative metabolism during constant work rate exercise is intensity-dependent in young individuals with mild-to-moderate CF.
  • Pulmonary V˙O2 kinetics are slowed during VH but not MOD cycling in pediatric CF patients.
  • The observed slowing of V˙O2 kinetics during VH exercise in CF appears mechanistically linked to impaired muscle O2 extraction and utilization.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
605
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
989